Company Monitoring Page for Astellas

latest headlines for company on cafepharma

Astellas readies roxadustat for launch
EP Vantage
Wed, 09/15/21 - 10:37 am
Tags:
Astellas, roxadustat, drug launches
Astellas reports fourth death in halted gene therapy trial
Pharmaforum
Tue, 09/14/21 - 10:59 am
Tags:
Astellas, gene therapy, AT132, patient deaths, clinical trials, X-linked myotubular myopathy
More trouble for Astellas as AT132 gene therapy trial is halted again
Pharmaforum
Wed, 09/1/21 - 11:02 am
Tags:
Astellas, gene therapy, AT132, clinical trials, X-linked myotubular myopathy
After FDA snub, EMA backs FibroGen, Astellas’ roxadustat
Pharmaforum
Fri, 08/20/21 - 10:51 am
Tags:
Europe, FibroGen, Astellas, Evrenzo, anemia, chronic kidney disease
FDA Approvals Roundup: Kerendia, Padcev, Darzalex Faspro
RAPS.org
Thu, 07/15/21 - 12:34 pm
Tags:
FDA, drug approvals, Bayer, Kerendia, Astellas, Padcev, Teva Pharmaceutical, ArmonAir RespiClick, Janssen, Darzalex Faspro
Pneumococcal Vaccine Snags Breakthrough Therapy Designation
BioSpace
Tue, 07/13/21 - 11:29 pm
Tags:
Astellas, Affinivax, vaccines, pneumococcal disease, breakthrough therapy
Seagen, Astellas' Padcev snares full approval and expands into second-line treatment on path to blockbuster land
Fierce Pharma
Sat, 07/10/21 - 12:00 am
Tags:
Astellas, Seagen, Padcev, FDA, bladder cancer
The big approvals still on the cards for 2021
EP Vantage
Thu, 06/17/21 - 11:00 am
Tags:
FDA, drug approvals, Argenx, Novartis, AstraZeneca, Astellas, UCB Pharma, Ascendis Pharma, ChemoCentryx, Axsome Therapeutics
#ASCO21: Ahead of August PDUFA date, Astellas and Seagen sweeten Padcev pitch with new data
Endpoints
Thu, 05/20/21 - 12:16 pm
Tags:
ASCO 2021, Astellas, Seagen, Padcev, FDA, urothelial cancer
Astellas quietly cuts Cytokinetics R&D pact as $450M-plus in biobucks goes up in smoke
Fierce Biotech
Mon, 05/3/21 - 10:51 am
Tags:
Astellas, Cytokinetics, biobucks
Astellas takes $540M impairment charge over Audentes' gene therapy trial hold
Fierce Biotech
Tue, 04/27/21 - 10:47 am
Tags:
Astellas, Audentes, AT132, gene therapy
Astellas innovation awards offer up ideas to ease cancer patients' pandemic burdens
Fierce Pharma
Tue, 04/20/21 - 07:36 pm
Tags:
Astellas, cancer, innovation
Seagen gets Au­gust PDU­FA for Pad­cev ex­pan­sions
Endpoints
Mon, 04/19/21 - 10:25 pm
Tags:
Seagen, FDA, Padcev, Astellas
Nearly a year after Audentes' gene therapy deaths, the trial continues. What happened remains a mystery
Endpoints
Wed, 04/14/21 - 09:37 am
Tags:
Audentes, Astellas, gene therapy, clinical trials
Big pharma freshens up
EP Vantage
Fri, 04/9/21 - 10:35 am
Tags:
Merck, Bristol Myers Squibb, Astellas, Novo Nordisk, AbbVie, Sanofi
Audentes CEO exits as Astellas rebrands a gene therapy buyout
BioPharma Dive
Thu, 04/1/21 - 11:01 am
Tags:
Astellas, Audentes, gene therapy, M&A, Astellas Gene Therapies
Astellas gene therapy repairs damage in neurodegenerative disease models
Fierce Biotech
Wed, 03/31/21 - 11:08 pm
Tags:
gene therapy, Astellas, Quethera, neurodegenerative disease
Astellas scores a pair of trial wins for menopausal hot flash med, raising the pitch of looming Bayer standoff
Endpoints
Fri, 02/19/21 - 10:27 am
Tags:
Astellas, clinical trials, fezolinetant, menopause, hot flashes
Asco-GU – confirmatory Padcev trial throws a curveball
EP Vantage
Fri, 02/12/21 - 10:59 am
Tags:
Astellas, Seagen, Padcev, bladder cancer, ASCO-GU
Aducanumab tops 2021’s biggest potential launches
EP Vantage
Mon, 01/18/21 - 01:04 pm
Tags:
drug launches, Biogen, Eisai, aducanumab, efgartigimod, Argenx, Evrenzo, FibroGen, Astellas, AstraZeneca, Leqvio, Novartis, UCB Pharma, bimekizumab, Ascendis Pharma, Bluebird Bio, Bristol-Myers Squibb, ide-cel, liso-cel, AXS-05, Axsome Therapeutics, voclosporin, Aurinia

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.